Publications by authors named "Ela Markovsky"

Claim this Profile
A
A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growth.
Einav Vax, Revital Caspi, Rachel Shukrun, Naomi Pode-Shakked, Oren Pleniceanu, Ela Markovsky

Front Bioeng Biotechnol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Acetylcysteine Amide Is a Potential Novel Radioprotector of Salivary Gland Function.
Amit Ritter, Elad Hikri, Hongyan Li, Ela Markovsky, Gideon Bachar

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models.
Ela Markovsky, Sadna Budhu, Robert M Samstein, Hongyan Li, James Russell

Int J Radiat Oncol Biol Phys· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation state of Ser in α-tubulin is a toggle switch that controls proliferating human breast tumors.
Ela Markovsky, Elisa de Stanchina, Aryeh Itzkowitz, Adriana Haimovitz-Friedman, Susan A Rotenberg

Cell Signal· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEGylated dendritic polyglycerol conjugate targeting NCAM-expressing neuroblastoma: Limitations and challenges.
Laura Isabel Vossen, Ela Markovsky, Anat Eldar-Boock, Harald Rune Tschiche, Stefanie Wedepohl

Nanomedicine· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib radio-sensitization of human sarcoma tumors.
Feng Wang, Hongyan Li, Ela Markovsky, Ryan Glass, Elisa de Stanchina

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine.
Ela Markovsky, Einav Vax, Dikla Ben-Shushan, Anat Eldar-Boock, Rachel Shukrun

Mol Cancer Ther· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
Hemda Baabur-Cohen, Laura Isabel Vossen, Harald Rune Krüger, Anat Eldar-Boock, Eilam Yeini, Ela Markovsky

J Control Release· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine.
Ela Markovsky, Anat Eldar-Boock, Dikla Ben-Shushan, Hemda Baabur-Cohen, Eilam Yeini

J Control Release· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
Ela Markovsky, Hemda Baabur-Cohen, Ronit Satchi-Fainaro

J Control Release· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming obstacles in microRNA delivery towards improved cancer therapy.
Dikla Ben-Shushan, Ela Markovsky, Hadas Gibori, Galia Tiram, Anna Scomparin

Drug Deliv Transl Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration, distribution, metabolism and elimination of polymer therapeutics.
Ela Markovsky, Hemda Baabur-Cohen, Anat Eldar-Boock, Liora Omer, Galia Tiram

J Control Release· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death.
Hila Epstein-Barash, Dikla Gutman, Ela Markovsky, Galit Mishan-Eisenberg, Nickolay Koroukhov

J Control Release· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition.
Ela Markovsky, Nickolay Koroukhov, Gershon Golomb

Nanomedicine (Lond)· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis